Chengdu Kanghong Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 6.5% in First Quarter of 2023
Listen to the full version

Chengdu Kanghong Pharmaceutical Group Co.,Ltd. (成都康弘药业集团股份有限公司) (002773.SZ) reported a net profit of 277.2 million yuan in the first quarter of 2023, down 6.5% year-on-year.
Meanwhile, the company posted 884.8 million yuan in revenue, down 1.2% year-on-year.
At the end of the reporting period, it had 7.9 billion yuan in total assets and 713.3 million yuan in total liabilities, with a liability-to-asset ratio of 9%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR